These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 29395165)
1. Anti-neutrophil cytoplasm antibodies (ANCA): Recent methodological advances-Lead to new consensus recommendations for ANCA detection. Csernok E; Mahrhold J; Hellmich B J Immunol Methods; 2018 May; 456():1-6. PubMed ID: 29395165 [TBL] [Abstract][Full Text] [Related]
2. [ANCA-associated vasculitis: recent methodological advances for ANCA detection]. Csernok E Dtsch Med Wochenschr; 2018 Apr; 143(7):499-502. PubMed ID: 29614541 [TBL] [Abstract][Full Text] [Related]
3. [Paradigm shift in ANCA diagnostics : New international consensus recommendations]. Csernok E; Kempiners N; Hellmich B Z Rheumatol; 2017 Mar; 76(2):143-148. PubMed ID: 28058500 [TBL] [Abstract][Full Text] [Related]
4. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Damoiseaux J; Csernok E; Rasmussen N; Moosig F; van Paassen P; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Bossuyt X Ann Rheum Dis; 2017 Apr; 76(4):647-653. PubMed ID: 27481830 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness. Avery TY; Bons J; van Paassen P; Damoiseaux J Lupus; 2016 Jul; 25(8):917-24. PubMed ID: 27252270 [TBL] [Abstract][Full Text] [Related]
6. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease. Savige J; Trevisin M; Pollock W J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145 [TBL] [Abstract][Full Text] [Related]
7. The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis. Guchelaar NAD; Waling MM; Adhin AA; van Daele PLA; Schreurs MWJ; Rombach SM Autoimmun Rev; 2021 Jan; 20(1):102716. PubMed ID: 33197574 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of PR3- and MPO-ANCA line and dot immunoassays in ANCA-associated vasculitis. Kempiners N; Mahrhold J; Hellmich B; Csernok E Rheumatology (Oxford); 2021 Sep; 60(9):4390-4394. PubMed ID: 33316047 [TBL] [Abstract][Full Text] [Related]
10. New concepts in ANCA detection and disease classification in small vessel vasculitis: the role of ANCA antigen specificity. Csernok E Mediterr J Rheumatol; 2018 Mar; 29(1):17-20. PubMed ID: 32185292 [TBL] [Abstract][Full Text] [Related]
11. EUROPLUS ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis. Damoiseaux J; Steller U; Buschtez M; Vaessen M; Rosemann A; van Paassen P; Stöcker W; Fechner K; Tervaert JW J Immunol Methods; 2009 Aug; 348(1-2):67-73. PubMed ID: 19615371 [TBL] [Abstract][Full Text] [Related]
12. The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis. Csernok E Antibodies (Basel); 2019 May; 8(2):. PubMed ID: 31544837 [TBL] [Abstract][Full Text] [Related]
13. [ANCA diagnostics in vasculitis]. Csernok E; Hellmich B Z Rheumatol; 2020 Sep; 79(7):669-678. PubMed ID: 32488364 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466 [TBL] [Abstract][Full Text] [Related]
15. Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis. Walker BS; Peterson LK; Koening C; White SK; Schmidt RL; Tebo AE Autoimmun Rev; 2022 Jun; 21(6):103100. PubMed ID: 35452854 [TBL] [Abstract][Full Text] [Related]
16. A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies. Bossuyt X; Rasmussen N; van Paassen P; Hellmich B; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Csernok E; Damoiseaux J Rheumatology (Oxford); 2017 Sep; 56(9):1533-1541. PubMed ID: 28541581 [TBL] [Abstract][Full Text] [Related]
17. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis. Holding S; Fisher VJ; Abuzakouk M Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222 [TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Radice A; Bianchi L; Sinico RA Autoimmun Rev; 2013 Feb; 12(4):487-95. PubMed ID: 22921790 [TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing. Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]